The 2025-26 Budget: Health Care Access and Information

Feb 20, 2025 - The agreement extends for a ten‑year period after the first commercial sale of the new product. According to HCAI, the partnership will produce three generic insulin products, with insulin glargine (also known by the brand name Lantus) most likely to be launched first.
https://lao.ca.gov/Publications/Report/4979

Building California’s Behavioral Health Infrastructure: Progress Update and Opportunities for the Proposition 1 Bond

Feb 5, 2025 - In one area where a robust needs assessment has been performed (inpatient mental health facilities), however, we found that a majority of new capacity is being added in four (out of ten) regions of the state estimated to have the least need.
https://lao.ca.gov/Publications/Report/4954